Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,231 public trials 93 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

NCT01288469

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number 840616 Mesa, Arizona, United States
  • Investigational Site Number 840601 Tucson, Arizona, United States
  • Investigational Site Number 840610 Los Angeles, California, United States
  • Investigational Site Number 840608 Newport Beach, California, United States
View all 20 locations
View Trial Details
Completed

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy

NCT01288443

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number 840525 Tempe, Arizona, United States
  • Investigational Site Number 840516 Los Angeles, California, United States
  • Investigational Site Number 840528 Mission Viejo, California, United States
  • Investigational Site Number 840509 Newport Beach, California, United States
View all 38 locations
View Trial Details
Completed

Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter

NCT01753232

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more
Locations
  • Nierenzentrum Mannheim Mannheim, Baden Würtemberg, Germany
  • Medizinisches Versorgungszentrum Kempten (Allgäu), Bavaria, Germany
  • Universitätsklinikum Regensburg Institut für Klinische Chemie und Laboratoriumsmedizin Regensburg, Bavaria, Germany
  • Dialysezentrum Potsdam Potsdam, Brandenburg, Germany
View Trial Details
Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

NCT01412034

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Clinical Research Facility Hartford, Connecticut, United States
  • Clinical Research Facility North Massapequa, New York, United States
  • Clinical Research Facility Chicoutimi, Quebec, Canada
  • Clinical Research Facility Québec, Quebec, Canada
View Trial Details

Related conditions